Shree Ganesh Bio

3
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE051N01026
  • NSEID:
  • BSEID: 539470
INR
0.63
0.00 (0.00%)
BSENSE

Dec 05

BSE+NSE Vol: 80.48 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 13.22% vs -67.53% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -424.65% vs -109.34% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is -55.15% vs -69.55% in Mar 2024

Compare Profit and Loss Results of Shree Ganesh Bio
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
22.00
86.00
-64.00
-74.42%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
22.00
86.00
-64.00
-74.42%
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
7.00
-9.00
-128.57%
Raw Materials Consumed
25.00
65.00
-40.00
-61.54%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
2.00
-2.00
-100.00%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
5.00
-5.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
24.00
88.00
-64.00
-72.73%
Operating Profit (PBDIT) excl Other Income
-1.00
-1.00
0.00
0.00%
Other Income
1.00
5.00
-4.00
-80.00%
Operating Profit (PBDIT)
0.00
4.00
-4.00
-100.00%
Interest
0.00
1.00
-1.00
-100.00%
Profit before Depriciation and Tax
0.00
2.00
-2.00
-100.00%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
0.00
1.00
-1.00
-100.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
1.00
-1.00
-100.00%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
0.00
0.00
0.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
17.00
8.00
9.00
112.50%
Profit Available for appropriations
17.00
8.00
9.00
112.50%
Appropriations
17.00
8.00
9.00
112.50%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.01
1.14
-1.13
-99.12%
Profit And Loss - Net Sales
Net Sales 22.96 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 13.22% vs -67.53% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) -1.05 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -424.65% vs -109.34% in Mar 2024

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 0.28 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -55.15% vs -69.55% in Mar 2024